Evidence map›Paper›PMID 29696167›Full record

ArticleContemporary clinical trials communications2017

Reasons for participating in a randomised clinical trial: The volunteers' voices in the COSTOP trial in Uganda.

Agnes Ssali, Andrew Nunn, Martin Mbonye, Zacchaeus Anywaine, Janet Seeley

Abstract read
In one paragraph

Article in Contemporary clinical trials communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Agnes SsaliMedical Research Council/UVRI Uganda Research Unit on AIDS, Uganda.
Andrew NunnMedical Research Council Clinical Trials Unit at University College, London, UK.
Martin MbonyeMedical Research Council/UVRI Uganda Research Unit on AIDS, Uganda.
Zacchaeus AnywaineMedical Research Council/UVRI Uganda Research Unit on AIDS, Uganda.
Janet SeeleyMedical Research Council/UVRI Uganda Research Unit on AIDS, Uganda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe reasons why research participants join clinical trials remains an area of inquiry especially in low and middle income countries.

methodsWe conducted exit interviews with participants who took part in a trial which aimed to evaluate whether long term prophylaxis with cotrimoxazole can be safely discontinued among adults who have been stabilised on antiretroviral therapy (ART). Participants were all reported to be stable on ART and had been participating in the trial for between 12 and 36 months; at the end of the trial participants were interviewed using a semi-structured questionnaire. One of the objectives of the exit interview was to find out what motivated the participants to join the research.

resultsParticipants gave personal reasons for joining the trial, frequently linked to their health and well-being as well as reduction of pill burden.

conclusionWe conclude that underlying reasons for joining clinical trials may extend beyond or can be different from the rationale given to the participants before enrolment by the research team. The reasons that motivate enrolment to clinical trials and research in general require further investigation in different settings. TRIAL REGISTRATION NUMBER: ISRCTN44723643.

Indexed as

ParticipantsRandomised clinical trialsVolunteers

Identifiers

PMID29696167
PMCPMC5898547

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.